LYMPHATIC FILARIASIS: AN OVERVIEW

  • KANAAN AL-TAMEEMI Department of Microbiology, Faculty of Pharmacy, Al Andalus University for Medical Sciences, Tartous, Syria.
  • RAIAAN KABAKLI Department of Basic Sciences, Faculty of Pharmacy, Al Andalus University for Medical Sciences, Tartous, Syria.

Abstract

Lymphatic filariasis (LF) is a tropical disease caused by infection with the parasitic filarial worms: Wuchereria bancrofti, Brugia malayi, and Brugia timori. The symptoms of this chronic disease appear in adults (in men more than in women) and include damage to the lymphatic system, arms, legs, and genitals, which cause significant pain, reducing productivity, and social problems. LF is a cause of continued disability, pain, disfigurement, and sexual disability in the world, so the knowledge of the disease and the infection control is very important. In addition to the importance of prevention, that includes giving medicine and using controlling ways of mosquitoes. Moreover, the prevention of disease is important, that includes giving medicine and using controlling ways of mosquitoes. However, although the efforts of health organizations to reduce the LF infections, there are still many challenges including the early diagnosis and control of infection among people.

Keywords: Lymphatic filariasis, Lymphedema, Hydrocele, Mosquitoes

Author Biography

KANAAN AL-TAMEEMI, Department of Microbiology, Faculty of Pharmacy, Al Andalus University for Medical Sciences, Tartous, Syria.

Ph.D.microbiolog

References

1. Tyagi BK. Lymphatic Filariasis Epidemiology, Treatment and Prevention, the Indian Perspective. Singapore: Springer Nature Singapore Pte Ltd.; 2018.
2. Chakraborty S, Gurusamy M, Zawieja DC, Muthuchamy M. Lymphatic filariasis: Perspectives on lymphatic remodeling and contractile dysfunction in filarial disease pathogenesis. Microcirculation 2013;20:349-64.
3. Liao S, Padera TP. Lymphatic function and immune regulation in health and disease. Lymphat Res Biol 2013;11:136-43.
4. Available from: https://www.who.int/news-room/fact-sheets/detail/lymphatic-filariasis.
5. Chandy A, Thakur AS, Singh MP, Manigauha A. A review of neglected tropical diseases: Filariasis. Asian Pac J Trop Med 2011;4:581-6.
6. Otsuji Y. History, epidemiology and control of filariasis. Trop Med Health 2011;39:3-13.
7. Goel TC, Goel A. Lymphatic Filariasis. Singapore: Springer Science+Business Media; 2016.
8. Gordon CA, Jones MK, McManus DP. The history of bancroftian lymphatic filariasis in Australasia and Oceania: Is there a threat of re-occurrence in mainland Australia? Trop Med Infect Dis 2018;3:E58.
9. Melrose W. Lymphatic Filariasis: A Review 1862-2002. Australia: Warwick Educational Publishing Inc.; 2004.
10. Sangshetti JN, Shinde DB, Kulkarnia A, Arotec R. Two decades of antifilarial drug discovery: A review. R Soc Chem 2017;7:20628-66.
11. Available from: https://www.who.int/lymphatic_filariasis/epidemiology/en.
12. Available from: https://www.cdc.gov/parasites/lymphaticfilariasis/epi.html.
13. World Health Organization, Frequently Asked Questions on Lymphatic Filariasis (Elephantiasis), World Health Organization, Regional Office for South-East Asia, Indraprastha Estate, Mahatma Gandhi Marg, New Delhi: World Health Organization; 2013.
14. World Health Organization. Lymphatic Filariasis: A Handbook of Practical Entomology for National Lymphatic Filariasis Elimination Programmes, Geneva, Switzerland: World Health Organization; 2013.
15. Misra-Bhattacharya S, Kushwaha S, Bajpai P. Water and Lymphatic Filariasis. India: Springer; 2014.
16. Pfarr KM, Debrah AY, Specht S, Hoerauf A. Filariasis and lymphedema. Parasite Immunol 2009;31:664-72.
17. World Health Organization. Training in Monitoring and Epidemiological Assessment of Mass Drug Administration for Eliminating Lymphatic Filariasis: Learners’ Guide. 1211 Geneva 27, Switzerland: World Health Organization; 2013.
18. Paily KP, Hoti SL, Das PK. A review of the complexity of biology of lymphatic filarial parasites. J Parasit Dis 2009;33:3-12.
19. Kazura JW. Tissue Nematodes (Trichinellosis, Dracunculiasis, Filariasis, Loiasis, and Onchocerciasis), Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 8th ed., Vol. 2. Philadelphia, PA: Saunders; 2015. p. 3208-15.
20. da Rosa Neves RP. Lymphatic Filariasis Detection in Microscopic Images, Document; 2016.
21. Hill CA, Shaunnessey C, MacDonald J. The Biology and Medical Importance of Mosquitoes in Indiana, Purdue University, Biology of Indiana Mosquitos, Purdue Master Gardener Program; 2013.
22. Harbach RE. The Phylogeny and Classification of Anopheles. Croatia: Harbach; Licensee InTech; 2013. p. 3-55.
23. Centres for Disease Control and Prevention, Parasites Lymphatic Filariasis. Available from: https://www.cdc.gov/parasites/lymphaticfilariasis/treatment.html. [Last accessed on 2018 Mar 16].
24. Mohammad FI. Filarial Worms. Int J Pharm Res 2018;45:89-93.
25. Bakowski MA, McNamara CW. Advances in antiwolbachial drug discovery for treatment of parasitic filarial worm infections. Trop Med Infect Dis 2019;4:E108.
26. Available from: https://www.cdc.gov/parasites/lymphaticfilariasis/biology.html.
27. National Organization for Rare Disorders (NORD), Filariasis. Available from: https://www.rarediseases.org/rare-diseases/filariasis.
28. World Health Organization. Lymphatic Filariasis: Managing Morbidity and Preventing Disability: An Aide-mémoire for National Programme Managers, Geneva, Switzerland: World Health Organization; 2013.
29. Kwarteng A, Ahuno ST, Akoto FO. Killing filarial nematode parasites: Role of treatment options and host immune response. Infect Dis Poverty 2016;5:86.
30. Otabil KB, Tenkorang SB. Filarial hydrocele: A neglected condition of a neglected tropical disease. J Infect Dev Ctries 2015;9:456-62.
31. Mullerpattan JB, Udwadia ZF, Udwadia FE. Tropical pulmonary eosinophilia a review. Indian J Med Res 2013;138:295-302.
32. Available from: https://www.lymphedematreatmentact.org/about-lymphedema.
33. Akturk HK, Gbadamosi-Akindele M. Elephantiasis nostras verrucosa. BMJ Case Rep 2014;2014:bcr2013200363.
34. Christiana O, Olajumoke M, Oyetunde S. Lymphatic filariasis and associated morbidities in rural communities of Ogun state, Southwestern Nigeria. Travel Med Infect Dis 2014;12:95-101.
35. Dietrich CF, Chaubal N, Hoerauf A, Kling K, Piontek MS, Steffgen L, et al. Review of dancing parasites in lymphatic filariasis. Ultrasound Int Open 2019;5:E65-E74.
36. Joseph H, Speare R, Melrose W. Laboratory diagnosis of lymphatic filariasis in Australia: Available laboratory diagnostic tools and interpretation. Aust J Med Sci 2012;33:1-40.
37. Daravath B, Reddy GS, Kamarapu SK. Development and validation of Rp-HPLC method for simultaneous estimation of chlorpheniramine maleate and diethylcarbamazine citrate in pharmaceutical dosage forms. Asian J Pharm Clin Res 2014;7:98-102.
38. Pion SD, Montavon C, Chesnais CB, Kamgno J, Wanji S, Klion AD, et al. Positivity of antigen tests used for diagnosis of lymphatic filariasis in individuals without Wuchereria bancrofti infection but with high loa loa microfilaremia. Am J Trop Med Hyg 2016;95:1417-23.
39. Turner JD, Sharma R, Al Jayoussi G, Tyrer HE, Gamble J, Hayward L, et al. Albendazole and antibiotics synergize to deliver short-course anti-Wolbachia curative treatments in preclinical models of filariasis. Proc Natl Acad Sci U S A 2017;114:E9712-E9721.
40. Ndeffo-Mbah ML, Galvani AP. Global elimination of lymphatic filariasis, global elimination of lymphatic filariasis. Lancet Infect Dis 2017;17:358-9.
41. World Health Organization. PAR part 4 Suppliers Submission of the SRA Approved the text. Malaysia: World Health Organization; 2016.
42. Kimura E, Mataika JU. Control of lymphatic filariasis by annual single-dose diethylcarbamazine treatments. Parasitol Today 1996;12:240-4.
43. Dakshinamoorthy G, Samykutty AK, Munirathinam G, Reddy MV, Kalyanasundaram R. Multivalent fusion protein vaccine for lymphatic filariasis. Vaccine 2013;31:1616-22.
Statistics
479 Views | 210 Downloads
Citatons
How to Cite
KANAAN AL-TAMEEMI, and RAIAAN KABAKLI. “LYMPHATIC FILARIASIS: AN OVERVIEW”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 12, no. 12, Oct. 2019, pp. 1-5, doi:10.22159/ajpcr.2019.v12i12.35646.
Section
Review Article(s)